• Fund Type: SICAV
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: International

Bellevue Funds Lux - BB Biotech

+ Add to Watchlist

BBBIOCI:LX

309.01 CHF 0.57 0.18%

As of 08:48:00 ET on 07/25/2014.

Snapshot for Bellevue Funds Lux - BB Biotech (BBBIOCI)

Year To Date: +13.90% 3-Month: +17.55% 3-Year: +33.30% 52-Week Range: 236.12 - 328.43
1-Month: +1.46% 1-Year: +23.18% 5-Year: +17.09% Beta vs LUXXX: 0.64

Mutual Fund Chart for BBBIOCI

No chart data available.
  • BBBIOCI:LX 309.01
  • 1M
  • 1Y
Interactive BBBIOCI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for BBBIOCI

Bellevue Funds (Lux) - BB Biotech is an open-end investment fund incorporated in Luxembourg. The Fund's objective is long-term capital appreciation. The Fund invests mainly in equities and equity related securities of companies that are directly involved in the biotechnology sector. The focus is on companies that develop, research, and market various technologies and products in this sector.

Inception Date: 04-02-2009 Telephone: 41-44-267-67-00
Managers: DANIEL KOLLER / TAZIO STORNI
Web Site: www.bellevuegroup.com

Fundamentals for BBBIOCI

NAV (on 2014-07-25) 309.01
Assets (M) (on 2014-07-25) 50.13
Fund Leveraged N
Minimum Investment 500,000.00
Minimum Subsequent Investment -

Dividends for BBBIOCI

No dividends reported

Fees & Expenses for BBBIOCI

Front Load -
Back Load 0.00
Current Mgmt Fee 0.90
Redemption Fee 0.00
12b1 Fee -
Expense Ratio -

Top Fund Holdings for BBBIOCI

Filing Date: 06/30/2014
Name Position Value % of Total
Celgene Corp 56,764 4,874,892 9.733%
Gilead Sciences Inc 57,326 4,752,899 9.489%
Biogen Idec Inc 14,647 4,618,346 9.220%
Vertex Pharmaceuticals Inc 25,071 2,373,722 4.739%
Alexion Pharmaceuticals Inc 15,146 2,366,563 4.725%
Amgen Inc 18,766 2,221,331 4.435%
Incyte Corp Ltd 34,352 1,938,827 3.871%
Regeneron Pharmaceuticals Inc 6,795 1,919,384 3.832%
Alkermes PLC 33,079 1,664,866 3.324%
Medivation Inc 21,346 1,645,350 3.285%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil